Aller-7™ Clinically Shown to Promote Respiratory Health and Normal Breathing

Over 40 million Americans suffer from allergic rhinitis or hay fever, characterized by inflamed and irritated nasal membranes. Recent studies have demonstrated the safety of Aller-7™ and shown that it can intervene in processes that produce symptoms such as sneezing, running nose, itchy and watery eyes. A three-phase clinical trial was conducted to evaluate the effectiveness of Aller-7™, a blend of seven medicinal plant extracts. In Phase I, 20 patients received 1320 mg of Aller-7™ (660 mgs twice daily) for 15 days. Phase II consisted of a double-blind, placebo-controlled evaluation of 1320 mg Aller-7™ (660 mgs twice daily) in 48 subjects over a 3 month period. In Phase III, 545 patients were given 1,320 mg (660 mgs twice daily) of the botanical formulation for 3 months in a multi-center clinical trial. Compared to those taking placebo, all patients treated with Aller-7™ experienced significant improvement in nasal congestion, runny nose, sneezing, peak nasal flow and mucocilliary clearance. These findings suggest that Aller-7™, at a daily dose of 1320 mg, can serve as a safe, natural dietary supplement to reduce the symptoms of allergic rhinitis.

Source: Bagchi M, Saxena VS, Pratibha N, Amit A, Bagchi D, Anti-Allergic Potential of a Novel Botanical Formulation (Aller-7) Against Allergic Rhinitis: Clinical Findings, Journal of the American College of Nutrition 22(5): Abs 46, 2003.